Skip to main content
. 2020 Nov 26;13:4609–4620. doi: 10.2147/DMSO.S282926

Table 2.

The Details of Insulin Regimens and Injection Techniques in Studied Participants

Total (N=400) T1DM (N=56) T2DM (N=344)
Insulin regimen

  • Mixed split

 155 (38.8%) 7 (12.5%) 148 (43.0%)

  • Basal bolus

 87 (21.8%) 43 (76.8%) 44 (12.8%)

  • Basal plus

 60 (15.0%) 5 (8.9%) 55 (16.0%)

  • Basal only

 86 (21.4%) – 86 (25.0%)

  • Others

 12 (3.0%) 1 (1.8%) 11 (3.2%)
Location of injection site

  • Abdomen

 371 (92.8%) 43 (76.8%) 328 (95.3%)

  • Thigh

 4 (1.0%) – 4 (1.2%)

  • Arm

 1 (0.2%) 1 (1.8%) –

  • Mixed

 23 (5.8%) 11 (19.6%) 12(3.5%)

  • Hip

 1 (0.2%) 1 (1.8%) –
Rotation injection site

  • Yes

 298 (74.5%) 41 (73.2%) 257 (74.7%)

  • No

 102 (25.5%) 15 (26.8%) 87 (25.3%)
Needle length

  • 4 mm

 20 (5.0%) 2 (3.6%) 18(5.2%)

  • 5 mm

 82 (20.5%) 13 (23.2%) 69 (20.1%)

  • 6 mm

 200 (50.0%) 27 (48.2%) 173 (50.3%)

  • 8 mm

 93 (23.2%) 11 (19.6%) 82 (23.8%)

  • Others

 5 (1.3%) 3 (5.4%) 2 (0.6%)
Reused insulin needles

  • Yes

 378 (94.5%) 53 (94.6%) 325 (94.5%)
3 times 88 (23.3%) 13 (24.5%) 75 (23.1%)
4–5 times 87 (23.0%) 10 (18.9%) 77 (23.7%)
>5 times 203 (53.7%) 30 (56.6%) 173 (53.2%)

  • No

 22 (5.5%) 3 (5.4%) 19 (5.5%)